Cell, Gene and Novel Therapies

Course Overview

Offered by UCL (University College London), the MSc Cell, Gene and Novel Therapies provides a comprehensive postgraduate education in biological sciences. Based in Camden, England, this Russell Group university offers a research-led approach to learning, with a 1-year full-time and part-time structure. The Cell, Gene and Novel Therapies MSc provides you with an in-depth insight into the cutting-edge and rapidly developing field of biological therapies. This programme covers all aspects of cell, gene and novel therapies, including applied genomics, the molecular basis of disease, stem cell biology and tissue repair, current and developing technologies in biomedical research and therapeutic intervention, and clinical applications. You will also receive training in research methodology and statistics. International tuition fees are £16,800 per year, home/UK fees are £8,400 per year, and a minimum IELTS score of 7.0 is required for admission. Graduates from this programme benefit from strong career prospects, with 82% student satisfaction rating, a median graduate salary of £30,500 within three years, a 95% continuation rate, and 73% of graduates in employment or further study.

What You'll Learn

Tuition Fees & Funding

Fees shown are for current entry. Fees may increase annually in line with inflation.

Graduate Outcomes

Frequently Asked Questions